NYSE:OMI - Owens & Minor Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $21.36
  • Forecasted Upside: -10.64 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$23.90
▼ -1.23 (-4.89%)
1 month | 3 months | 12 months
Get New Owens & Minor Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OMI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OMI

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$21.36
▼ -10.64% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Owens & Minor in the last 3 months. The average price target is $21.36, with a high forecast of $34.00 and a low forecast of $9.50. The average price target represents a -10.64% upside from the last price of $23.90.
Hold
The current consensus among 7 investment analysts is to hold stock in Owens & Minor. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/27/2020

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/5/2020UBS GroupBoost Price TargetNeutral$13.00 ➝ $27.00High
i
11/4/2020BarclaysBoost Price TargetEqual Weight$20.00 ➝ $23.00High
i
9/25/2020CSFBBoost Price TargetNeutral$18.00 ➝ $22.00Low
i
9/25/2020Credit Suisse GroupBoost Price TargetNeutral$18.00 ➝ $22.00Medium
i
Rating by Jailendra Singh at Credit Suisse Group AG
9/25/2020BarclaysUpgradeUnderweight ➝ Equal Weight$20.00Low
i
9/24/2020Robert W. BairdBoost Price TargetOutperform$21.00 ➝ $34.00High
i
Rating by Eric Coldwell at Robert W. Baird
8/7/2020Credit Suisse GroupLower Price TargetNeutral$17.00 ➝ $16.00Low
i
Rating by Jailendra Singh at Credit Suisse Group AG
7/22/2020BarclaysBoost Price TargetUnderweight$4.00 ➝ $10.00High
i
7/21/2020Robert W. BairdUpgradeNeutral ➝ Outperform$8.00 ➝ $14.00High
i
7/21/2020Bank of AmericaUpgradeNeutral ➝ Buy$8.00 ➝ $12.00High
i
6/10/2020CfraBoost Price TargetBuy$8.50 ➝ $9.50High
i
5/7/2020CfraLower Price TargetBuy$11.00 ➝ $8.50Low
i
5/5/2020Robert W. BairdDowngradeOutperform ➝ Neutral$8.00High
i
Rating by Eric Coldwell at Robert W. Baird
4/22/2020Credit Suisse GroupInitiated CoverageNeutral$8.00Low
i
3/30/2020CfraUpgradeHold ➝ Buy$5.50 ➝ $9.00High
i
1/21/2020Robert W. BairdUpgradeNeutral ➝ Outperform$9.00High
i
9/6/2019Bank of AmericaBoost Price TargetNeutral$4.00 ➝ $7.50Medium
i
4/10/2019Bank of AmericaReiterated RatingNeutral$7.00 ➝ $4.50High
i
2/21/2019BarclaysReiterated RatingSell$5.00Medium
i
2/21/2019Jefferies Financial GroupReiterated RatingHold$7.00Low
i
1/17/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$8.00High
i
1/6/2019BarclaysReiterated RatingSell$6.00Low
i
1/3/2019Bank of AmericaLower Price TargetNeutral ➝ Neutral$11.00 ➝ $7.00Medium
i
11/2/2018Jefferies Financial GroupReiterated RatingHold$8.50High
i
11/1/2018BarclaysReiterated RatingUnderweight ➝ Underweight$12.00 ➝ $8.00High
i
10/31/2018SVB LeerinkSet Price TargetHold$9.00High
i
Rating by David Larsen at SVB Leerink LLC
10/31/2018Bank of AmericaDowngradeBuy ➝ NeutralHigh
i
3/8/2018BarclaysInitiated CoverageUnderweight ➝ Underweight$16.00Medium
i
2/27/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$19.00Low
i
2/15/2018JPMorgan Chase & Co.Lower Price TargetUnderweight ➝ Underweight$21.00 ➝ $20.00Low
i
12/19/2017JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Underweight$22.00High
i
11/20/2017Credit Suisse GroupReiterated RatingUnderperform$31.00 ➝ $17.00N/A
i
11/2/2017SVB LeerinkReiterated RatingMarket Perform$34.00 ➝ $23.00N/A
i
10/12/2017Robert W. BairdReiterated RatingHold$28.00N/A
i
9/1/2017Robert W. BairdUpgradeUnderperform ➝ Neutral$28.00Medium
i
8/9/2017Jefferies Financial GroupReiterated RatingHold$36.00 ➝ $32.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
8/9/2017UBS GroupReiterated RatingSell$30.50 ➝ $29.50Medium
i
8/3/2017UBS GroupReiterated RatingSell$30.50 ➝ $29.50Medium
i
7/7/2017Jefferies Financial GroupReiterated RatingHold$36.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
5/22/2017Jefferies Financial GroupSet Price TargetHold$36.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
4/21/2017Jefferies Financial GroupReiterated RatingHold$36.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
3/16/2017Jefferies Financial GroupSet Price TargetHold$36.00Medium
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
11/7/2016Bank of AmericaDowngradeNeutral ➝ Underperform$32.00N/A
i
10/5/2016UBS GroupInitiated CoverageSell$31.50N/A
i
9/12/2016Bank of AmericaInitiated CoverageNeutralN/A
i
5/5/2016SVB LeerinkReiterated RatingHoldN/A
i
4/21/2016Robert W. BairdDowngradeNeutral ➝ Underperform$36.00 ➝ $32.00N/A
i
4/12/2016UBS GroupReiterated RatingSell$31.00N/A
i
3/15/2016Credit Suisse GroupInitiated CoverageUnderperform$36.00N/A
i
12/7/2015Royal Bank of CanadaBoost Price TargetSector Perform$35.00 ➝ $36.00N/A
i
(Data available from 11/27/2015 forward)
Owens & Minor logo
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.
Read More

Today's Range

Now: $23.90
$23.59
$25.45

50 Day Range

MA: $24.78
$22.17
$27.30

52 Week Range

Now: $23.90
$3.63
$27.75

Volume

31,874 shs

Average Volume

2,448,051 shs

Market Capitalization

$1.76 billion

P/E Ratio

N/A

Dividend Yield

0.04%

Beta

0.34